A mesothelioma diagnosis changes everything. Almost immediately, families find themselves learning a new vocabulary. Pleural. Peritoneal. Latency. Staging. HIPEC. Cytoreductive surgery. A few weeks ago, these words meant nothing. Now, they carry enormous weight because the path forward depends on understanding them.
Of all the treatment options available for mesothelioma, cytoreductive surgery is one of the most significant and one of the most misunderstood. For the right patient, at the right stage, and with the right surgical team, it offers a chance at meaningful survival that other treatments alone cannot match. For patients who are not candidates, understanding why they are not eligible and knowing what other options exist matters just as much.
This page is for patients, spouses, children, and other family members trying to understand what cytoreductive surgery actually is, what it involves, and how it fits into the larger picture of mesothelioma treatment and the fight for compensation.
The attorneys at Lipsitz, Ponterio & Comerford have spent decades representing mesothelioma patients and their families. We understand both the medical and the legal sides of this disease, and we work alongside families during treatment, not just after. Call (716) 849-0701 or request a free case consultation to speak with our team and explore the legal options available to you during this difficult time.
Cytoreductive surgery, often shortened to CRS, is a surgical procedure designed to reduce, as completely as possible, the visible cancer in the body. For mesothelioma, this means the surgical team works to remove every tumor deposit they can identify and reach, often down to nodules just a few millimeters across.
The goal is not simply to take out a tumor and close up. The goal is what surgeons call complete cytoreduction, meaning that no visible disease remains at the end of the operation. When that goal is achieved, the patient has the best possible chance of responding to any follow-on therapies that come next.
Cytoreductive surgery is used for two different forms of mesothelioma, and the specific operation looks different depending on which form a patient has.
Peritoneal mesothelioma affects the lining of the abdomen. For patients with peritoneal disease who qualify for surgery, the operation is typically cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy, or HIPEC.
During CRS, the surgical team opens the abdomen and systematically removes all visible tumors. This can involve removing portions of the peritoneum (the membrane lining the abdomen), sections of the intestine, the omentum, the spleen, and other abdominal structures where mesothelioma has spread. The procedure often takes many hours.
After the cytoreductive portion is complete, the surgical team administers HIPEC. Heated chemotherapy solution, typically warmed to around 41 to 43 degrees Celsius, is circulated through the abdominal cavity for roughly 60 to 90 minutes. The heat enhances the cancer-killing effect of the chemotherapy and helps it target microscopic disease that the surgical removal could not eliminate. Because the chemotherapy is delivered directly to the abdomen rather than through the bloodstream, much higher concentrations can be used.
The combination of CRS and HIPEC has produced survival results that would have been unimaginable a generation ago. Patients eligible for the treatment have achieved survival far beyond what chemotherapy alone offers.
Pleural mesothelioma affects the lining of the lungs. For patients with pleural disease who qualify for surgery, the two main cytoreductive surgeries are pleurectomy/decortication (P/D) and extrapleural pneumonectomy (EPP).
Pleurectomy/decortication, often called P/D, removes the diseased pleural lining from around the lung and strips tumors off the surface of the lung itself, along with affected portions of the diaphragm and pericardium when needed. The lung is preserved. P/D has become the more commonly recommended surgery for most pleural mesothelioma patients at specialized centers.
Extrapleural pneumonectomy, or EPP, is a more extensive operation. It removes the entire lung along with the pleura, the affected portion of the diaphragm, and part of the pericardium. The missing diaphragm and pericardium are reconstructed with surgical patches. EPP was historically the standard aggressive operation for pleural mesothelioma, though many experienced centers now favor P/D when possible because it preserves lung function and has a lower operative mortality.
Both operations are demanding. Both require surgical teams with specific mesothelioma experience. And both are typically combined with chemotherapy, radiation, or other therapies as part of a multimodal treatment plan.
Not every mesothelioma patient is a surgical candidate. The decision depends on multiple factors, and families often find that this is one of the more difficult conversations they will have with the medical team.
Generally speaking, surgical candidacy depends on:
A patient who is told at one hospital that they are not a surgical candidate is sometimes told something different at a specialized mesothelioma center. Mesothelioma is rare, and experience with it matters enormously. Evaluations at high-volume mesothelioma programs are often worth pursuing when families have the chance.
Pre-operative evaluation typically includes extensive imaging (CT, MRI, and/or PET scans), cardiac and pulmonary testing, and consultation with the surgical team, oncology team, and anesthesia team. Patients often have a pre-operative laparoscopy or thoracoscopy to assess the extent of disease before committing to a full operation. Families should expect detailed discussions of risks, benefits, recovery expectations, and contingency plans.
Cytoreductive surgery for mesothelioma is a major operation. CRS with HIPEC for peritoneal mesothelioma often lasts eight to twelve hours or more. Pleural operations for pleural mesothelioma are similarly demanding. Patients go from the operating room to an intensive care unit for close post-operative monitoring.
Hospital stays after CRS with HIPEC typically range from ten days to several weeks, depending on how the patient tolerates the operation and whether any complications develop. Pleural surgery hospital stays are generally shorter but still significant. Patients work with physical therapy, nutrition, and pain management teams during recovery.
Full recovery from cytoreductive surgery takes months, not weeks. During the first several weeks, patients typically need substantial help at home, and energy returns slowly. Weight lost during hospitalization takes time to reverse. If follow-up chemotherapy is planned, it generally begins only after the patient has recovered enough to tolerate it.
Patients who undergo cytoreductive surgery are followed closely for years afterward with regular imaging and lab work to watch for any signs of recurrence. Ongoing coordination between surgical, medical oncology, and supportive care teams is essential.
Families navigating treatment decisions do not have to navigate the legal side alone, either. You can reach Lipsitz, Ponterio & Comerford directly at (716) 849-0701. Speaking with us is completely free and comes with no obligation.
Cytoreductive surgery is one of the most resource-intensive procedures in modern oncology. Between the surgery itself, the hospital stay, the HIPEC or multimodal components, the ICU care, and the follow-on therapies, total treatment costs often run into hundreds of thousands of dollars. Even patients with good insurance face meaningful out-of-pocket expenses, travel costs to reach specialized centers, lost income during extended recovery, and the costs of home support during the months that follow.
This is where the legal side of mesothelioma becomes deeply practical. The companies that manufactured asbestos-containing products, many of which knew the dangers and kept selling anyway, are responsible for the exposures that cause this disease. The legal claims brought against those companies, and the trust funds established by bankrupt asbestos manufacturers, exist specifically to compensate the patients and families affected. That compensation can help cover treatment, replace lost income, pay for travel to specialized centers, and provide financial security for the family during and after the treatment journey.
Pursuing compensation does not interfere with treatment. The legal and medical processes run in parallel. A good mesothelioma firm handles the paperwork, the investigation, the filings, and the negotiations so the family can stay focused on the patient and the medical team.
General personal injury firms take mesothelioma cases from time to time, but they do not typically have the infrastructure to serve families during treatment. The process looks very different when the patient is still being actively treated, when decisions are being made about surgery, when out-of-state centers are being considered, and when the family needs support rather than just representation. Retaining a firm that concentrates on mesothelioma cases means working with a team built for exactly this situation.
The attorneys at Lipsitz, Ponterio & Comerford have focused on mesothelioma and asbestos litigation for decades. We know the specialized treatment centers, the doctors who do this work, the medical experts who can document the disease, the industrial hygienists who can reconstruct exposure histories, and the specific products and companies that caused these diseases in the first place.
Our firm works with families at whatever stage they are in. Some come to us newly diagnosed, before treatment decisions have been made. Others come during treatment. Others come after a loved one has passed away. What all of them have in common is the need for a firm that understands mesothelioma specifically, knows how to move quickly when necessary, and treats families with the respect the situation requires.
Mesothelioma cases are time-sensitive for several reasons. New York law sets deadlines on these claims, and those deadlines cannot be extended once they pass. Beyond the legal deadlines, cases are built on evidence, and evidence is easier to gather when the patient is still living and able to provide information about work history, product exposure, and daily tasks. Claims filed while the patient is alive also proceed on different legal footing than claims filed after death.
None of this means decisions need to be made immediately. It simply means that an early conversation protects the family’s options, often at exactly the time when the family’s attention is rightly focused on the medical side. At Lipsitz, Ponterio & Comerford, that conversation is free and carries no obligation.
If you or a loved one has been diagnosed with mesothelioma and is considering cytoreductive surgery, or trying to understand whether it is even an option, you do not have to navigate this alone. The medical team will guide the treatment decisions. Our firm can help with everything else.
When you reach out to Lipsitz, Ponterio & Comerford for a case evaluation, you’re simply starting a conversation. An experienced attorney will take the time to understand your situation—the diagnosis, the exposure history, the questions you’re carrying—and give you straightforward guidance on whether a claim is worth pursuing and what that process would involve. There’s no pressure and no obligation.
Whether the patient is newly diagnosed, in the middle of treatment, post-surgical recovery, or has passed away, whether the exposure happened last year or fifty years ago, whether you have all the details or only a vague sense of the work history, reaching out is the right next step.
To speak with our team, call (716) 849-0701 today, or arrange a free case review online. There’s no charge for the conversation, and everything discussed is completely confidential. Families going through this deserve straightforward answers and genuine care, and that’s exactly what we aim to provide.
Lipsitz, Ponterio & Comerford, LLC. Representing workers and families across Western New York in mesothelioma, asbestos, and talc-related cases.
We hope that you will never be diagnosed with mesothelioma, lung cancer, or suffer a catastrophic injury, but if you are, contact us at Lipsitz, Ponterio & Comerford so we can begin the fight.
Call Today: 866-238-1452 or fill out the online form.
Your state’s law may limit your time to file a legal claim. For a free and confidential case evaluation, please complete this form.
Asbestos Contaminated Talcum Powder Causes Mesothelioma. Learn more about Asbestos, Talcum Powder and your legal rights here.